Mireia Coll-Tané

Mireia Coll-Tané

Auto-generated profile, based on publicly available information

Mireia Coll-Tané

Department of Human Genetics, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
MCMireia Coll-Tané
Mireia Coll-Tané
NGNaihua N. Gong
Naihua N. Gong
SBSamuel J. Belfer
Samuel J. Belfer
LRLara V. van Renssen
Lara V. van Renssen
EKEvangeline C. Kurtz-Nelson
Evangeline C. Kurtz-Nelson
ASAnnette Schenck
Annette Schenck
Sleep disturbances in autism and neurodevelopmental disorders are common and adversely affect patient’s quality of life, yet the underlying mechanisms are understudied. We found that individuals with mutations in CHD8, among the highest-confidence autism risk genes, or CHD7 suffer from disturbed sleep maintenance. These defects are recapitulated in Drosophila mutants affecting kismet, the sole CHD8/CHD7 ortholog. We show that Kismet is required in glia for early developmental and adult sleep architecture. This role localizes to subperineurial glia constituting the blood-brain barrier. We demonstrate that Kismet-related sleep disturbances are caused by high serotonin during development, paralleling a well-established but genetically unsolved autism endophenotype. Despite their developmental origin, Kismet’s sleep architecture defects can be reversed in adulthood by a behavioral regime resembling human sleep restriction therapy. Our findings provide fundamental insights into glial regulation of sleep and propose a causal mechanistic link between the CHD8/CHD7/Kismet family, developmental hyperserotonemia, and autism-associated sleep disturbances.

17 February 2026 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MCMireia Coll-Tané
Mireia Coll-Tané
IEIlse Eidhof
Ilse Eidhof
JHJie Han
Jie Han
NRNicholas Raun
Nicholas Raun
LRLara V. van Renssen
Lara V. van Renssen
ASAnnette Schenck
Annette Schenck
Sleep disturbances are among the most prevalent clinical features of FOXP1 syndrome, yet their nature and underlying mechanisms remain unclear. Here, we report that individuals with FOXP1 syndrome suffer from insomnia with sleep maintenance problems and early waking. Consistently, common variants in FOXP genes were associated with insomnia symptoms and short sleep. These sleep disturbances were recapitulated in Drosophila FoxP mutants, which exhibit severely fragmented and reduced sleep. FoxP loss also led to circadian arrhythmicity and impaired the plasticity of neuropeptide pigment dispersing factor–secreting (PDF-secreting) neurons in a non-cell-autonomous manner. FoxP was required during development for adult sleep integrity, particularly in peptidergic neurons. Transcriptomic analyses revealed a dysregulation of genes involved in peptidergic signaling, including hugin . FoxP was expressed in hugin + neurons (afferent to PDF-secreting neurons) during development, and its knockdown in these cells was sufficient to induce sleep fragmentation. Our findings establish an evolutionarily conserved role for FOXP proteins in the peptidergic regulation of sleep.

3 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MCMireia Coll-Tané
Mireia Coll-Tané
LRLara V. van Renssen
Lara V. van Renssen
NRNicholas Raun
Nicholas Raun
JHJie Han
Jie Han
NRNúria Ribas Ros
Núria Ribas Ros
ASAnnette Schenck
Annette Schenck
Sleep disturbances are a common, still poorly characterized feature of Kleefstra syndrome (KLEFS1), a neurodevelopmental disorder caused by rare variants in the epigenetic regulator EHMT1 . The gap in understanding the characteristics and origin of these sleep disturbances poses a major barrier for therapy development. In this cross-species study, we reveal that 70% of individuals with KLEFS1 experience severe sleep maintenance insomnia, marked by fragmented sleep due to frequent night awakenings. Furthermore, common genetic variation at the EHMT1 locus was associated with short sleep and insomnia symptoms in the general population. Drosophila mutants of the EHMT1 orthologue G9a recapitulate these phenotypes, exhibiting reduced and fragmented sleep. We show that G9a is required in insulin-producing cells (IPCs) and the fat body, in the latter during development, to ensure adult sleep integrity. Untargeted metabolomics revealed widespread metabolic dysregulation in G9a mutants, particularly affecting methionine metabolism. Mutants exhibited reduced methionine and elevated methionine sulfoxide (Met-SO), pointing to increased reactive oxygen species (ROS). Redox sensors revealed increased H 2 O 2 -dependent oxidation in the larval brain and an elevated glutathione redox potential in IPCs during development but not in adulthood. IPC-specific knockdown of MsrA , the enzyme that reduces Met-SO back to methionine, reproduced sleep fragmentation. Developmental, but not acute, antioxidant treatment fully restored adult sleep consolidation, demonstrating that G9a safeguards sleep via ROS homeostasis in early life. Finally, we show that a Drosophila sleep-restriction paradigm based on human sleep-restriction therapy can override the developmental defects and restore sleep continuity in adulthood. Our findings establish an evolutionarily conserved role for EHMT1/G9a in sleep regulation and provide a mechanistic framework to understand and treat sleep disturbances in KLEFS1.

31 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SJSpencer G. Jones
Spencer G. Jones
ABArianne Bouman
Arianne Bouman
NRNicholas Raun
Nicholas Raun
EGEvelien A.J. van Genugten
Evelien A.J. van Genugten
IMIsabel Martínez-Blázquez
Isabel Martínez-Blázquez
ASAnnette Schenck
Annette Schenck
Developmental regression is a severe but poorly understood complication of several neurodevelopmental disorders. In Kleefstra syndrome (KLEFS1), caused by EHMT1 haploinsufficiency, regression often emerges during adolescence or early adulthood and is frequently preceded by marked sleep disturbance. Experimental work implicating EHMT1/G9a in metabolic regulation and stress responses raises the possibility that impaired metabolic resilience contributes to this vulnerability. Here, we aimed to investigate whether altered glucose metabolism is a feature of KLEFS1 and whether it relates to clinical variability, including regression. Through [ 18 F]FDG-PET/CT, individuals with KLEFS1 who had experienced regression (n=4) exhibited a hypometabolic brain profile, whereas one individual who had not experienced regression showed globally elevated metabolic activity. In parallel, G9a mutant flies exhibited increased baseline metabolic rate and neuronal ATP levels together with sleep fragmentation resembling the clinical phenotype. Providing flies with oxidative stress to model KLEFS1 regression further exacerbated sleep disruption and was associated with a reduction in metabolic output. Importantly, adult high sugar feeding in flies prevented oxidative stress-induced worsening of sleep and maintained metabolic stability under challenge. Together, these findings suggest that regression in KLEFS1 and associated sleep disturbances are linked to underlying metabolic vulnerability and impaired maintenance of energy homeostasis under stress.

6 February 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
JLJingyi Long
Jingyi Long
SJSpencer G. Jones
Spencer G. Jones
ASAna Serna
Ana Serna
BRBoyd van Reijmersdal
Boyd van Reijmersdal
FKFranziska Kampshoff
Franziska Kampshoff
ASAnnette Schenck
Annette Schenck
Epilepsy is a mechanistically complex, incompletely understood neurological disorder. To uncover novel converging mechanisms in epilepsy, we used Drosophila whole-brain single-cell RNA-sequencing to refine and characterize a previously proposed human epilepsy-associated gene co-expression network (GCN). We identified a conserved co-expressed module of 26 genes, which comprises fly orthologs of 13 epilepsy-associated genes and integrates synaptic and metabolic functions. Over one-third of the Drosophila pan-neuronal knockdown models targeting this module exhibited altered seizure-like behaviors in response to mechanical or heat stress. These recapitulated seizures associated with four epilepsy-associated genes, identified two novel epilepsy candidate genes, and three genes knockdown of which conferred seizure protection. Most knockdown models with altered seizure susceptibility showed changes in metabolic rate and levels of phosphorylated adenosine monophosphate-activated protein kinase (AMPK), a key regulator of cellular energy homeostasis. Enhancing AMPK activity increased seizure resistance in a dose-dependent manner. Our findings show that Drosophila single-cell expression data and behavior can aid functional validation of human GCNs and highlight a role for metabolism in modifying seizure susceptibility. SUMMARY STATEMENT Integrating Drosophila single-cell RNA-sequencing data with seizure-like behavior and metabolic rate assays, we functionally characterized a human epilepsy-associated gene network, revealing metabolic regulation as a critical factor underlying seizure susceptibilities.

1 January 2026 in Disease Models & Mechanisms
Verified
Journal Article
Open access
JLJingyi Long
Jingyi Long
SJSpencer G. Jones
Spencer G. Jones
ASAna Serna
Ana Serna
BRBoyd van Reijmersdal
Boyd van Reijmersdal
FKFranziska Kampshoff
Franziska Kampshoff
ASAnnette Schenck
Annette Schenck
Epilepsy is a mechanistically complex, incompletely understood neurological disorder. To uncover novel converging mechanisms in epilepsy, we used Drosophila whole-brain single-cell RNA sequencing to refine and characterize a previously proposed human epilepsy-associated gene co-expression network (GCN). We identified a conserved co-expressed module of 26 genes, which comprises fly orthologs of 13 epilepsy-associated genes and integrates synaptic and metabolic functions. Over one-third of the Drosophila pan-neuronal knockdown models targeting this module exhibited altered seizure-like behaviors in response to mechanical or heat stress. These knockdown models recapitulated seizures associated with four epilepsy-associated genes and identified two novel epilepsy candidate genes and three genes for which knockdown conferred seizure protection. Most knockdown models with altered seizure susceptibility showed changes in metabolic rate and levels of phosphorylated adenosine monophosphate-activated protein kinase (AMPK), a key regulator of cellular energy homeostasis. Enhancing AMPK activity increased seizure resistance in a dose-dependent manner. Our findings show that Drosophila single-cell expression data and behavior can aid functional validation of human GCNs and highlight a role for metabolism in modifying seizure susceptibility.